AGRF Expands Olink® Platform with Signature Q100, Boosting Biomarker Discovery and Prognosis Capabilities
Posted: 27 November 2024 AGRF is thrilled to announce the expansion of its Olink® fleet with the addition of the Olink Signature Q100. This platform joins our certified Olink Explore HT and Explore 3072 workflows, further enhancing our…
Innovation and insights for digital care as the Royal Melbourne Hospital partners with ANDHealth
Posted: 27 November 2024 The Royal Melbourne Hospital (RMH) will gain early access and insights to some of Australia’s most innovative digital and connected health solutions after signing a partnership with ANDHealth, Australia’s leading digital health commercialisation company.…
Aptar Named Among Top 50 of the World’s Top Companies for Women 2024 by Forbes
Posted: 27 November 2024 AptarGroup, Inc. (NYSE: ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today announced that it has been named a World’s Top Companies for Women 2024 by Forbes for the fourth consecutive year…
Aptar Digital Health Partners with the University of Geneva to Advance Migraine Research
Posted: 27 November 2024 Aptar Digital Health, a global leader in digital health solutions, connected devices, data and study services, today announced a collaboration with the Quality of Life (QoL) technologies lab, University of Geneva, Switzerland, to advance…
Almac’s Singapore facility secures GMP Certification
Posted: 27 November 2024 Almac Clinical Services’ facility in Singapore has received Good Manufacturing Practice certification from the Health Sciences Authority, for cell, tissue and gene therapy products. This certification demonstrates our commitment to upholding the highest standards…
CSIRO solar venture nets record seed funding to accelerate clean energy transition
Posted: 27 November 2024 FPR Energy, a new venture from CSIRO, Australia’s national science agency, has secured $15 million in seed funding to commercialise next generation solar thermal technology that will help reduce industrial emissions, which account for…
Funds to better understand Friedreich ataxia drug
Posted: 27 November 2024 Associate Professor Shiang (Max) Lim, of SVI’s O’Brien Department, has been awarded funding from the Friedreich’s Ataxia Research Alliance (FARA) to better understand the effect of omaveloxolone – a recently FDA-approved drug – on…
St Vincent’s Allied Health Excellence Awards highlight patient care, innovation and leadership
Posted: 27 November 2024 St Vincent’s Hospital Melbourne has honoured its 2024 Allied Health Excellence Awards winners, recognising the pivotal role allied health professionals play in delivering high-quality, multidisciplinary care. With over 60 nominations from more than 500 allied health employees, the awards highlighted the…
Enabling circular economy practices in sustainable metal production
Posted: 27 November 2024 Researchers in the DIAMETER project will develop digital platforms focused on augmented sustainability and circularity of additive manufacturing and machining processes. A new four-year project has been awarded €6 million (AUD$9.7 million) by the…
Insights from BioForum’s fireside chat with Marissa Senzaki, featuring Ashwin Ramanchandra: How smart talent strategies drive the success of sustainable ventures
Posted: 27 November 2024 Talent. It’s often said to be the single biggest asset of any company, yet for startups – especially in the healthtech and biotech sectors – attracting, retaining and empowering the right people is one…
New hope for diabetic heart disease treatment
Posted: 27 November 2024 Monash University drug discovery researchers have found that a natural fat molecule called ‘lipoxin A4’ (LXA4) could significantly reduce inflammation and improve function for diabetic hearts. The preclinical study, published in Cardiovascular Diabetology, found LXA4, which…
Monash-led research is expanding treatment options for high cholesterol
Posted: 27 November 2024 Melbourne researchers are helping expand options for people with high cholesterol that puts them at risk of heart attack or stroke, including world-first drugs for potentially deadly conditions. Monash University and Monash Health are…
